The DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index.
Drug treatments in Alzheimer’s disease
Open accessAbstract
Despite the significant public health issue that it poses, only five medical treatments have been approved for Alzheimer's disease (AD) and these act to control symptoms rather than alter the course of the disease. Studies of potential disease-modifying therapy have generally been undertaken in patients with clinically detectable disease, yet evidence suggests that the pathological changes associated with AD begin several years before this. It is possible that pharmacological therapy may be beneficial in this pre-clinical stage before the neurodegenerative process is established. Techniques providing earlier diagnosis, such as cerebrospinal fluid biomarkers and amyloid positron emission tomography neuroimaging, are key to testing this theory in clinical trials. Recent results from trials of agents such as aducanumab are encouraging but must also be interpreted with caution. Such medicines could potentially delay the onset of dementia and would therefore markedly reduce its prevalence. However, we currently remain a good distance away from clinically available disease-modifying therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Current treatments for AD, including cholinesterase inhibitors and memantine, offer limited symptom relief, especially in the early to moderate stages, but do not halt disease progression or address the underlying neurodegeneration.”
From Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer’s Treatment: Systematic Review (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Four drugs (donepezil, memantine, galantamine, rivastigmine) are approved on the market and belong to two families: anticholinesterase inhibitors and anti-glutaminergics.”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [155]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60461-5 · Cited by 3,689
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
Bloom (2014) · doi:10.1001/jamaneurol.2013.5847 · Cited by 2,194
Jack, C. R., Albert, M. S., Knopman, D. S., McKhann, G. M., Sperling, R. A., Carrillo, M. C., Thies, B., & Phelps, C. H. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.004 · Cited by 2,042
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960
Research works printed but not linked: 1
- Mosconi, 2010, Pre-clinical detection of Alzheimer’s disease using FDG-PET, with or without amyloid imaging, J Alzheimers Dis, 20, 843, 10.3233/JAD-2010-091504 · DOI
Cited by
Sorted by citations
Items 101–200 of 576
Rudd, K. D., Lawler, K., Callisaya, M. L., & Alty, J. (2023) · GeroScience · doi:10.1007/s11357-023-00844-z · Cited by 37
Alternative autophagy: mechanisms and roles in different diseases
Feng, H., Wang, N., Zhang, N., & Liao, H.-H. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00851-1 · Cited by 39
Gautam, D., Naik, U. P., Naik, M. U., Yadav, S. K., Chaurasia, R. N., & Dash, D. (2023) · Biomolecules · doi:10.3390/biom13111609 · Cited by 38
Yong, Y.-Y., Yan, L., Wang, B.-D., Fan, D., Guo, M., Yu, L., Wu, J., Qin, D., Law, B. Y. K., Wong, V. K.-W., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155463 · Cited by 37
Bhat, A. A., Moglad, E. H. O., Goyal, A., Afzal, M., Thapa, R., Almalki, W. H., Kazmi, I. A., Alzarea, S. I., Ali, H., Gaur, A., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123056 · Cited by 38
Huang, X., Yang, J., Huang, X., Zhang, Z., Liu, J., Zou, L., & Yang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.632843 · Cited by 36
Qin, X., Xiang, Y., Liu, Y., Chen, Y., He, Q., Chen, T., Tang, L., He, B., & Li, J. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1468561 · Cited by 35
Wang, R., & Zhang, J. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111080 · Cited by 35
Vera, D. M., Rosell‐Valle, C., López-Gambero, A. J., Navarro, J. A., Zambrana-Infantes, E. N., Rivera, P., Santín, L. J., Suárez, J., & de Fonseca, F. R. (2020) · Biology · doi:10.3390/biology9110377 · Cited by 35
Abdelwahab, G. M., Mira, A., Cheng, Y., Abdelaziz, T. A., Lahloub, M., & Khalil, A. T. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257071 · Cited by 35
Salvo, C. D., D’Antongiovanni, V., Benvenuti, L., d’Amati, A., Ippolito, C., Segnani, C., Pierucci, C., Bellini, G., Annese, T., Virgintino, D., et al. (2024) · Food & Function · doi:10.1039/d4fo02075h · Cited by 37
Rationale for the development of an Alzheimer’s disease vaccine
Kwan, P., Konno, H., Chan, K. Y., & Baum, L. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1665453 · Cited by 35
Silva, S., Marto, J. M., Gonçalves, L., Almeida, A. J., & Vale, N. (2020) · Nanomaterials · doi:10.3390/nano10102089 · Cited by 34
New RNA-Based Breakthroughs in Alzheimer’s Disease Diagnosis and Therapeutics
Riscado, M., Baptista, B., & de Sousa, F. P. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091397 · Cited by 34
Cai, H.-Y., Qiao, J., Chen, S., Yang, J., Hölscher, C., Wang, Z., Qi, J., & Wu, M. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022138 · Cited by 35
Batool, Z., Chen, J., Gao, Y., Lu, L. W., Xu, H., Liu, B., Wang, M., & Chen, F. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c06206 · Cited by 33
New horizons in the diagnosis and management of Alzheimer’s Disease in older adults
Dolphin, H., Dyer, A. H., Morrison, L., Shenkin, S. D., Welsh, T. J., & Kennelly, S. (2024) · Age and Ageing · doi:10.1093/ageing/afae005 · Cited by 33
Self-citationZhou, X., Zhang, Y., Jiang, Y., Zhou, C., & Ling, Y. (2021) · Neuroreport · doi:10.1097/wnr.0000000000001648 · Cited by 33
Haddad, H. W., Malone, G. W., Comardelle, N. J., Degueure, A. E., Poliwoda, S., Kaye, R. J., Murnane, K. S., Kaye, A. M., & Kaye, A. D. (2022) · Health Psychology Research · doi:10.52965/001c.37023 · Cited by 35
Tseng, P., Chen, Y., Zeng, B., Zeng, B., Hung, C., Sun, C., Cheng, Y., Stubbs, B., Carvalho, A. F., Brunoni, A. R., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01164-2 · Cited by 33
Kletzel, S., Sood, P., Negm, A. M., Heyn, P. C., Krishnan, S., Machtinger, J., Hu, X., & Devos, H. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.05.022 · Cited by 35
Effects of Non-Invasive Brain Stimulation on Alzheimer's Disease
Gu, L., Xu, H., & Qian, F. K. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.40 · Cited by 32
Particulate matter and Alzheimer’s disease: an intimate connection
O’Piela, D. R., Durisek, G., Escobar, Y.-N. H., Mackos, A. R., & Wold, L. E. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.06.004 · Cited by 36
Regulatory mechanisms of tetramethylpyrazine on central nervous system diseases: A review
Liu, Y., Yang, G., Cui, W., Zhang, Y., & Liang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.948600 · Cited by 32
Young, S., Chung, E. C., & Chen, M. A. (2021) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.21.0079 · Cited by 34
A new perspective on Alzheimer’s disease: m6A modification
Xia, L., Zhang, F., Li, Y., Mo, Y., Zhang, L., Li, Q., Luo, M., Hou, X., Du, Z., Deng, J., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1166831 · Cited by 32
Klann, I. P., Martini, F., Rosa, S. G., & Nogueira, C. W. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05326-5 · Cited by 31
ALNasser, M. N., Alboraiy, G. M., Alsowig, E. M., & Alqattan, F. M. (2025) · Brain Sciences · doi:10.3390/brainsci15020215 · Cited by 35
“It is used for moderate-to-severe AD and can be combined with ChEIs to improve cognitive function [8–10].”
Zhang, X., Shi, N., Chen, M., Liu, M., Ju, R.-J., Liu, Y., Kong, L., Yu, Y., & Li, X. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2216405 · Cited by 31
Kim, J. H., Meng, H. W., He, M. T., Choi, J. M., Lee, D., & Cho, E. J. (2020) · Molecules · doi:10.3390/molecules25173942 · Cited by 31
Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview
Štrac, D. Š., Konjevod, M., Šagud, M., Perković, M. N., Erjavec, G. N., Vuić, B., Šimić, G., Vukić, V., Mimica, N., & Pivac, N. (2021) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s284615 · Cited by 30
Chen, X., Li, L., Sharma, A., Dhiman, G., & Vimal, S. (2021) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-021-00450-7 · Cited by 30
Targeting Necroptosis as a Promising Therapy for Alzheimer’s Disease
Zhao, W., Liu, Y., Xu, L., He, Y., Cai, Z., Yu, J., Zhang, W., Xing, C., Zhuang, C., & Qu, Z. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00172 · Cited by 31
Jones, K. T., Ostrand, A. E., Gazzaley, A. H., & Zanto, T. P. (2023) · Scientific Reports · doi:10.1038/s41598-023-34582-1 · Cited by 29
Using Xenopus oocytes in neurological disease drug discovery
Zeng, S. L., Sudlow, L. C., & Berezin, M. Y. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1682993 · Cited by 30
Shared pathophysiology: Understanding stroke and Alzheimer’s disease
Sriram, S., Mehkri, Y., Quintin, S. S., & Lucke-Wold, B. P. (2022) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2022.107306 · Cited by 29
Villarreal, S. A., Zhao, F., Hyde, L. A., Holder, D., Forest, T. W., Sondey, M., Chen, X., Sur, C., Parker, E. M., & Kennedy, M. E. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170056 · Cited by 30
Li, N., Wang, Y., Li, W., Li, H., Yang, L., Wang, J., Mahdy, H. A., Mehany, A. B. M., Jaiash, D. A., Santali, E. Y., et al. (2020) · Journal of Chemistry · doi:10.1155/2020/1631243 · Cited by 29
Peña-Bautista, C., Vigor, C., Galano, J.-M., Oger, C., Durand, T., Ferrer, I., Cuevas, A., López-Cuevas, R., Baquero, M., López-Nogueroles, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50837-2 · Cited by 28
Identification of New Targets and the Virtual Screening of Lignans against Alzheimer’s Disease
Maia, M. D. S., Rodrigues, G. C. S., de Sousa, N. F., Scotti, M. T., Scotti, L., & Mendonça, F. J. B. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3098673 · Cited by 29
MicroRNA‑4722‑5p and microRNA‑615‑3p serve as potential biomarkers for Alzheimer's disease
Liu, Y., Xu, Y., & Yu, M. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11166 · Cited by 29
HIF-1α serves as a co-linker between AD and T2DM
Yang, H. T., Ren, K., Zhang, Y., Yang, L., Cao, H., Yuan, X., Su, L., Li, H., Feng, X., & Liu, D. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116158 · Cited by 28
The Role of Reactive Oxygen Species in Alzheimer's Disease: From Mechanism to Biomaterials Therapy
Yu, Z., & Luo, F. H. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304373 · Cited by 30
Assessing and projecting the global impacts of Alzheimer’s disease
Zhang, N., Chai, S., & Wang, J. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1453489 · Cited by 27
Tyrosol 1,2,3-triazole analogues as new acetylcholinesterase (AChE) inhibitors
Bousada, G. M., de Sousa, B. L., Furlani, G. M., Agrizzi, A. P., Ferreira, P. G., Leite, J. P. V., Mendes, T. A. D. O., Varejão, E. V. V., Pilau, E. J., & dos Santos, M. H. (2020) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2020.107359 · Cited by 27
He, H., Yang, Y., Wang, L., Guo, Z., Ye, L., Ou-Yang, W., & Yang, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1182307 · Cited by 27
Insight into the Double-Edged Role of Ferroptosis in Disease
Zhang, L., Jia, R., Li, H., Yu, H., Ren, K., Jia, S., Li, Y., & Wang, Q. (2021) · Biomolecules · doi:10.3390/biom11121790 · Cited by 26
Aducanumab: A new hope in Alzheimer's disease
Ali, R., Gupta, G. D., & Chawla, P. A. (2022) · Health Sciences Review · doi:10.1016/j.hsr.2022.100039 · Cited by 31
Han, K., Tang, Z., Bai, Z., Su, W., & Zhang, H. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.878025 · Cited by 26
Role of Polyphenols in Alleviating Alzheimer’s Disease: A Review
Raja, T. R. W., Duraipandiyan, V., Ignacimuthu, S., Janakiraman, U., & Packiam, S. M. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867330666221202152540 · Cited by 26
Zeng, P. H., Fang, M., Zhao, H., & Guo, J. (2021) · Aging · doi:10.18632/aging.203348 · Cited by 26
He, Z., Li, X., Wang, Z., Tu, S., Feng, J., Du, X., Ni, J., Li, N., & Liu, Q. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.153956 · Cited by 25
Budak, M., Bayraktaroğlu, Z., & Hanoğlu, L. (2022) · Cognitive Neurodynamics · doi:10.1007/s11571-022-09818-x · Cited by 25
Jeong, W.-H., Kim, W.-I., Lee, J.-W., Park, H., Song, M., Choi, I., & Han, J. (2021) · Brain Sciences · doi:10.3390/brainsci11111532 · Cited by 24
Lee, J.-E., Kwon, S., Jin, C., Cho, S., Park, S.-U., Jung, W., Moon, S., Park, J., Ko, C., & Cho, K. (2022) · Pharmaceuticals · doi:10.3390/ph15020174 · Cited by 24
Weng, G., Zhou, B., Liu, T., Huang, Z., & Huang, S. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s290030 · Cited by 23
Panda, S. P., & Soni, U. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101560 · Cited by 22
Ojo, A. B., Gyebi, G. A., Alabi, O. O., Iyobhebhe, M. E., Kayode, A. B., Nwonuma, C. O., & Ojo, O. A. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.133675 · Cited by 23
Zhu, Z., Liao, L., & Qiao, H. (2022) · Acupuncture and Herbal Medicine · doi:10.1097/hm9.0000000000000039 · Cited by 22
Ca2+ homeostasis in brain microvascular endothelial cells
Stoica, R., Rusu, C. M., Staicu, C. E., Burlacu, A., Radu, M., & Radu, B. M. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.01.001 · Cited by 23
Dunk, M. M., Driscoll, I. F., & Initiative, A. D. N. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215091 · Cited by 24
Shi, J., Chen, J., Xie, X., Li, Y., Ye, W., Yao, J., Zhang, X., Zhang, T., & Gao, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1132857 · Cited by 22
Jones, K. T., Gallen, C. L., Ostrand, A. E., Rojas, J. C., Wais, P. E., Rini, J. F., Chan, B., Lago, A. L., Boxer, A. L., Zhao, M., et al. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.04.005 · Cited by 23
Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment
Olloquequi, J., Ettcheto, M., Cano, A. C., Fortuna, A. C., Bicker, J., Sánchez‐López, E., Paz, C., Ureña, J. M., Verdaguer, E., Auladell, C., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814177 · Cited by 25
das Neves, A. M., Berwaldt, G. A., de Ávila, C. T., Goulart, T. B., Moreira, B. S. D. S., Ferreira, T. P., Soares, M. S. P., Pedra, N. S., Spohr, L., Souza, A. A. A. D., et al. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1680659 · Cited by 23
Guo, Y., Wu, Y., Li, N., & Wang, Z. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104587 · Cited by 22
Liu, Z., Cecarini, V., Cuccioloni, M., Bonfili, L., Gong, C., Angeletti, M., & Eleuteri, A. M. (2024) · Antioxidants · doi:10.3390/antiox13030310 · Cited by 21
Wang, H., Pan, J., Zhang, M., & Tan, Z. F. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1599048 · Cited by 28
Wang, H., Zong, Y., Han, Y., Zhao, J. P., Liu, H., & Liu, Y. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2027905 · Cited by 21
Zondagh, L. S., Malan, S. F., & Joubert, J. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1801673 · Cited by 22
Effects of Low-Intensity Transcranial Pulsed Ultrasound Treatment in a Model of Alzheimer's Disease
Tramontin, N. D. S., Silveira, P. C. L., Tietbohl, L. T. W., Pereira, B. D. C., Simon, K. R., & Muller, A. P. (2021) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2021.05.007 · Cited by 20
MiR‐483‐3p improves learning and memory abilities via XPO1 in Alzheimer's disease
Luo, G., Wang, X., & Liu, C. (2022) · Brain and Behavior · doi:10.1002/brb3.2680 · Cited by 20
Matrine exerts its neuroprotective effects by modulating multiple neuronal pathways
Chhabra, S., & Mehan, S. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01214-6 · Cited by 21
Ajiboye, B. O., Akalabu, M. C., Ojo, O. A., Afolabi, O. B., Okesola, M. A., Olayide, I., & Oyinloye, B. E. (2018) · Journal of Food Biochemistry · doi:10.1111/jfbc.12643 · Cited by 20
Ghaffari, M. S., Sanadgol, N., & Abdollahi, M. R. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200513122357 · Cited by 20
Wang, H., Liu, N., Zhang, S., Yang, Y., Wang, Z., Wei, Y., Liu, J., Pei, H., & Li, H. (2020) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-019-2718-2 · Cited by 19
Impaired Dopamine Release and Latent Learning in Alzheimer’s Disease Model Zebrafish
Jarošová, R., Niyangoda, S. S., Hettiarachchi, P., & Johnson, M. A. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00484 · Cited by 19
da Silva, P. R., Andrade, J., de Sousa, N. F., Portela, A. C. R., Pires, H. F. O., Remígio, M. C. R. B., Alves, D. D. N., de Andrade, H. H. N., Dias, A. L., Salvadori, M. G. D. S. S., et al. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230221123059 · Cited by 19
Ye, J., Wu, J., Ai, L., Zhu, M., Li, Y., Yin, D., & Huang, Q. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116296 · Cited by 20
Süzgeç‐Selçuk, S., Özek, T., Özek, G., Yur, S., Göğer, F., Gürdal, B., Toplan, G. G., Mericli, A. H., & Başer, K. H. C. (2020) · Records of Natural Products · doi:10.25135/rnp.185.20.03.1579 · Cited by 19
Hu, G., Shi, Z., Shao, W., & Xu, B. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.10.016 · Cited by 19
Sulfonamide Derivatives: Recent Compounds with Potent Anti-alzheimer’s Disease Activity
Egbujor, M. C. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249278489231128042135 · Cited by 18
Tau proteins and senescent Cells: Targeting aging pathways in Alzheimer’s disease
Singh, M., Ali, H., Jyothi, S. R., Kaur, I., Kumar, S., Sharma, N., Prasad, G. V. S., Pramanik, A., Almalki, W. H., & Imran, M. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149165 · Cited by 18
Basurto‐Islas, G., Diaz, M. C., Zavala-Ocampo, L. M., Martínez‐Herrera, M., & López-Camacho, P. Y. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.202400721 · Cited by 20
Genetic deletion of Rnd3 suppresses apoptosis through NF‑κB signaling in the brain
Dong, H., Sun, Q., Zhang, Y., Li, Y., Yuan, F., Mao, S., & Liu, B. (2020) · Oncology Reports · doi:10.3892/or.2020.7884 · Cited by 18
Wang, J., Liu, P., Huang, X., & Wu, X. (2020) · Annals of Palliative Medicine · doi:10.21037/apm-20-357 · Cited by 18
Butyrylcholinesterase-inhibiting natural coumarin molecules as potential leads
Orhan, İ. E., Tosun, F., Şenol, F. S., Eren, G., Mıhoğlugil, F., Akalgan, D., & Miski, M. (2021) · Phytochemistry Letters · doi:10.1016/j.phytol.2021.05.001 · Cited by 18
Zhang, P., Wang, Z., Mou, C., Zou, J., Xie, Y., Liu, Z., Naman, C. B., Mao, Y., Wei, J., Huang, X., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105387 · Cited by 18
Risk Factors for Mild Cognitive Impairment in German Primary Care Practices
Jacob, L., Bohlken, J., & Kostev, K. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160875 · Cited by 19
ElMosbah, D. E., Khattab, M. S., Ibrahim, M. A., El-Assal, M. I. A., & Miniawy, H. M. F. E. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01541-9 · Cited by 18
Sodium propionate improves cognitive and memory function in mouse models of Alzheimer's disease
Lang, W., Li, X., Wang, Y., Duan, Y., Wang, Y., PengSheng, W., Li, X., Zhu, Q., & Cui, Y. J. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136887 · Cited by 17
Wang, Q., Chen, S., Wang, J., Shang, H., & Chen, X. (2024) · Brain Sciences · doi:10.3390/brainsci14100990 · Cited by 18
Thangsiri, S., Inthachat, W., Temviriyanukul, P., Sahasakul, Y., Trisonthi, P., Pan-utai, W., Siriwan, D., & Suttisansanee, U. (2024) · Scientific Reports · doi:10.1038/s41598-024-74492-4 · Cited by 20
Advancements in the treatment of Alzheimer's disease: a comprehensive review
Rajanna, S., Gundale, P. P., & Mahadevaiah, A. D. (2025) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2024-0204 · Cited by 20
Al-Dekah, A. M., & Sweileh, W. M. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-101169 · Cited by 19
Wu, S., Zhang, J., Jiang, C., Wang, S., Que, R., & An, L. (2020) · Food & Function · doi:10.1039/d0fo00161a · Cited by 16
Zhou, Y., Li, J., Han, Y., Su, R., Huang, Y., Huang, Y., Li, Z., Wu, Y., Luo, H., Zhang, C., et al. (2021) · Molecules · doi:10.3390/molecules26103034 · Cited by 16
Yue, J., Li, X., Gao, R.-X., Zhang, Q., Li, A., Zhao, W.-W., Li, Y., & Li, S. (2022) · Medicine · doi:10.1097/md.0000000000030858 · Cited by 16
Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms
Vuić, B., Milos, T., Tudor, L., Perković, M. N., Konjevod, M., Erjavec, G. N., Farkaš, V., Uzun, S., Mimica, N., & Štrac, D. Š. (2023) · Genes · doi:10.3390/genes14112048 · Cited by 17
Recent progresses in natural based therapeutic materials for Alzheimer's disease
Zivari‐Ghader, T., Valioğlu, F., Eftekhari, A., Aliyeva, I., Beylerli, O., Davran, S., Cho, W. C. S., Beilerli, A., Khalilov, R. I., & Javadov, S. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26351 · Cited by 17
Metadata
- Authors
- Briggs, R., Kennelly, S. P., & O’Neill, D.
- Affiliations
- Tallaght University Hospital (IE)
- Venue
- Clinical Medicine
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 16
- Issue
- 3
- Pages
- 247-253
- ISSN
- 1470-2118 (ISSN-L)
- PMC
- PMC5922703
- OpenAlex
- W2415242066
- Cited by
- 571
- References
- 76
- Citations by year
- 2026: 37 · 2025: 67 · 2024: 97 · 2023: 79 · 2022: 106 · 2021: 95 · 2020: 55 · 2019: 18 · 2018: 5 · 2017: 9 · 2016: 2
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Clinical Medicine (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, pharmacotherapy, disease-modifying therapy, symptomatic treatment, preclinical Alzheimer's disease, cerebrospinal fluid biomarkers, amyloid PET, aducanumab, early diagnosis, dementia prevention
- MeSH terms
- Alzheimer Disease, Amyloid, Cholinesterase Inhibitors, Humans, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
